Created at Source Raw Value Validated value
Oct. 17, 2022, 10:36 a.m. usa

platform inclusion criteria: age ≥ 18 years admitted to an acute-care hospital confirmed sars-cov-2 by nucleic acid testing or rapid antigen testing in the 14 days prior to randomisation able to be randomised within 14 days of symptom onset at least one symptom or sign attributable to sars-cov-2 infection

platform inclusion criteria: age ≥ 18 years admitted to an acute-care hospital confirmed sars-cov-2 by nucleic acid testing or rapid antigen testing in the 14 days prior to randomisation able to be randomised within 14 days of symptom onset at least one symptom or sign attributable to sars-cov-2 infection

Nov. 16, 2021, 6:30 p.m. usa

platform inclusion criteria: age ≥ 18 years admitted to an acute-care hospital confirmed sars-cov-2 by nucleic acid testing in the past 14 days able to be randomised within 14 days of symptom onset at least one symptom or sign attributable to sars-cov-2 infection

platform inclusion criteria: age ≥ 18 years admitted to an acute-care hospital confirmed sars-cov-2 by nucleic acid testing in the past 14 days able to be randomised within 14 days of symptom onset at least one symptom or sign attributable to sars-cov-2 infection

Jan. 29, 2021, 12:31 a.m. usa

platform inclusion criteria: 1. age ≥ 18 years 2. admitted to an acute-care hospital 3. confirmed sars-cov-2 by nucleic acid testing in the past 14 days 4. able to be randomised within 14 days of symptom onset 5. at least one symptom or sign attributable to sars-cov-2 infection

platform inclusion criteria: 1. age ≥ 18 years 2. admitted to an acute-care hospital 3. confirmed sars-cov-2 by nucleic acid testing in the past 14 days 4. able to be randomised within 14 days of symptom onset 5. at least one symptom or sign attributable to sars-cov-2 infection

Oct. 26, 2020, 11:31 p.m. usa

inclusion criteria: 1. age ≥ 18 years 2. confirmed sars-cov-2 by nucleic acid testing in the past 12 days 3. able to be randomised within 12 days of symptom onset 4. expected to be remain an inpatient for at least 48 hours from the time of randomisation

inclusion criteria: 1. age ≥ 18 years 2. confirmed sars-cov-2 by nucleic acid testing in the past 12 days 3. able to be randomised within 12 days of symptom onset 4. expected to be remain an inpatient for at least 48 hours from the time of randomisation